Trials / Completed
CompletedNCT05812742
Chasing Biomarkers in Post-concussion Syndrome
Neurofilament Light Chain, Inflammatory Markers, Calcitonin Gene-related Peptide, and Kynurenine Metabolites in Patients With Severe Post-concussive Symptoms
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 86 (actual)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study was to investigate the biomarkers, neurofilament light chain, inflammatory markers, calcitonin-gene-related peptide, and metabolites from the kynurenine pathway in patients with severe post-concussive symptoms. The main question it aimed to answer was: * Are the biomarker concentrations significantly changed in patients with severe post-concussive symptoms compared to healthy individuals? * Do the biomarker concentrations change at follow-up? Participants were recruited from a recently published randomized controlled trial (Clinicaltrials.gov no. NCT02337101 / PMID: 31891145 ). The biomarker concentrations were compared to a healthy control group recruited from the Blood Bank at Aarhus University Hospital in 2022.
Detailed description
In the previously published RCT-study (PMID: 31891145), 86 participants with severe post-concussive symptoms provided blood samples at baseline (4 months after the concussion). Severe post-concussive symptoms were defined as having a Rivermead Post Concussion Questionnaire \>20. Around 7 months later, a follow-up blood sample was obtained from 54 participants. These blood samples were used to investigate blood biomarkers for the condition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Early intervention programme | For more information, please go to the original registration of the RCT-study (NCT02337101) or the published article (PMID: 31891145). |
| BEHAVIORAL | Enhanced usual care | For more information, please go to the original registration of the RCT-study (NCT02337101) or the published article (PMID: 31891145). |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2023-07-01
- Completion
- 2023-07-01
- First posted
- 2023-04-14
- Last updated
- 2024-04-16
Source: ClinicalTrials.gov record NCT05812742. Inclusion in this directory is not an endorsement.